Crinetics Pharmaceuticals (NASDAQ:CRNX) Given “Overweight” Rating at Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a report published on Friday morning, Benzinga reports. They currently have a $50.00 price objective on the stock. Several other research firms have also commented on CRNX. Morgan Stanley initiated coverage on shares of Crinetics Pharmaceuticals in a research […]
More Stories
Falcon Oil & Gas (CVE:FO) Share Price Crosses Below Fifty Day Moving Average – Here’s Why
Shares of Falcon Oil & Gas Ltd. (CVE:FO – Get Free Report) passed below its 50-day moving average during trading...
JBS (OTCMKTS:JBSAY) Shares Pass Below Fifty Day Moving Average – Should You Sell?
Shares of Jbs S.A. (OTCMKTS:JBSAY – Get Free Report) crossed below its 50-day moving average during trading on Thursday ....
The Character Group (LON:CCT) Share Price Crosses Above Fifty Day Moving Average – What’s Next?
The Character Group plc (LON:CCT – Get Free Report)’s share price passed above its 50-day moving average during trading on...
Wilmar International (OTCMKTS:WLMIY) Stock Passes Below Fifty Day Moving Average – Time to Sell?
Wilmar International Limited (OTCMKTS:WLMIY – Get Free Report)’s share price passed below its 50 day moving average during trading on...
Sabine Royalty Trust (NYSE:SBR) Increases Dividend to $0.45 Per Share
Sabine Royalty Trust (NYSE:SBR – Get Free Report) announced a dividend on Friday, January 3rd,NASDAQ Dividends reports. Shareholders of record...
Deutsche Börse (OTCMKTS:DBOEY) Share Price Passes Above 200 Day Moving Average – Time to Sell?
Shares of Deutsche Börse AG (OTCMKTS:DBOEY – Get Free Report) crossed above its 200-day moving average during trading on Thursday...